High Dose 7S-Immunoglobulin Treatment in Myasthenia Gravis

  • S. Knorr-Held
  • M. Wick
  • H. Kissel
  • A. Fateh-Moghadam
  • U. A. Besinger
  • M. Albiez
Part of the Verhandlungen der Deutschen Gesellschaft für Neurologie book series (VDGNEUROLOGIE, volume 4)

Abstract

High-dose 7S-intravenous immunoglobulins (7S i.v.IG) have been demon strated to improve acute autoimmune idiopathic thrombocytopenic purpura (ITP) in children (1).

References

  1. 1.
    Imbach P, Barandun S, d’Apuzzo V et al. (1981) High dose intravenous gamma-globuline for idiopathic thrombocytopenic purpura in childhood. Lancet 1228–1231Google Scholar
  2. 2.
    Besinger UA, Toyka KV, Hömberg M et al. (1983) Myasthenia gravis: Long term of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity. Neurology (NY) 33(10):1316–1321Google Scholar
  3. 3.
    Fateh-Moghadam A, Wick M, Besinger UA, Geursen RG (1984) High dose intravenous gammaglobuline for myasthenia gravis. Lancet 848–849Google Scholar
  4. 4.
    Stockinger B, Lemmel EM (1978) Fc-receptor dependancy of antibody mediated feedback regulation: On the mechanism of inhibition. Cell Immunol 40:395–403PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1987

Authors and Affiliations

  • S. Knorr-Held
  • M. Wick
  • H. Kissel
  • A. Fateh-Moghadam
  • U. A. Besinger
  • M. Albiez

There are no affiliations available

Personalised recommendations